This site is intended for heath plan professionals in Canada.

This site is intended for health plan professionals in Canada.

U.S. professionals should visit ManagedCareCGM.com

Continuous Glucose Monitoring

Continuous Glucose Monitoring - CGM

Insights & Education for Health Benefit Plan Professionals in Canada

Using CGM to Aid in Virtual Care and Improve Diabetes Management

Unveiling the Latest Evidence:
CGM’s Evolving Impact on Diabetes Care

CGM Improves Glycemic Control and
Reduces CVD Risk in Non-Insulin-Treated T2D 

Next-Generation Dexcom G7 CGM
System Approved by Health Canada

ADA 2023 Highlights:
The Clinical and Economic Value of CGM


Watch Now

Social Experiences of Living with Diabetes in Canada

Social Experiences of Living with Diabetes in Canada  – Diabetes Canada – September, 2024

Read More

Large, Real-World Retrospective Study Shows Reduced Health Care Resource Utilization and Improved Glycemic Outcomes with CGM in T2D Regardless of Treatment Type

Large, Real-World Retrospective Study Shows Reduced Health Care Resource Utilization and Improved Glycemic Outcomes with CGM in T2D Regardless of Treatment Type  – Diabetes Obesity Metabolism – July, 2024

Read More

2024 Vancouver Benefits Summit

2024 Vancouver Benefits Summit: How Connected Diabetes Care Platforms Can Help Plan Members Better Manage Their Condition  – BenefitsCanada.com – July, 2024

Read More

Using Continuous Glucose Monitoring to Aid in Virtual Care and Improve Diabetes Management

Using Continuous Glucose Monitoring to Aid in Virtual Care and Improve Diabetes Management  – CanadaCGM.com – May 30, 2024

Read More

Continuing Education Programs: Improving Health Outcomes with CGM

CGM Continuing Education Programs: Improving Health Outcomes with CGM- CanadaCGM.com – October 7, 2024

Read More

Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies

Evidence-Based Rationale for Expanding Access to CGM in Individuals with Type 2 Diabetes Treated with Nonintensive Therapies – Diabetes Technology & Therapeutics – August 2023

Read More

Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes

Large, Single-Center Study Shows that Increased Utilization of Technology Significantly Improved Glycemic Outcomes in Type 1 Diabetes – American Diabetes Association – July 17, 2023

Read More

Next-Generation Dexcom G7 CGM System Approved by Health Canada

Next-Generation Dexcom G7 CGM System Approved by Health Canada – Business Wire – July 4, 2023

Read More

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible

At Home Use of Closed Loop Insulin System in Pregnancy Determined to be Feasible – Diabetes Care – May 17, 2023

Read More

A review of the symposium: “Eureka Moments: How Real-time Continuous Blood Glucose Monitoring (rtCGM) Has Changed Our Practice”

A review of the Symposium: “Eureka Moments: How Real-Time Continuous Blood Glucose Monitoring (rtCGM) has Changed Our Practice”  – The Diabetes Communicator (Page 11) – Winter 2023

Read More